Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Total Current Liabilities (2018 - 2025)

AdaptHealth (AHCO) has 8 years of Total Current Liabilities data on record, last reported at $712.4 million in Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 25.65% year-over-year to $712.4 million; the TTM value through Dec 2025 reached $712.4 million, up 25.65%, while the annual FY2025 figure was $712.4 million, 25.65% up from the prior year.
  • Total Current Liabilities reached $712.4 million in Q4 2025 per AHCO's latest filing, up from $670.7 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $712.4 million in Q4 2025 and bottomed at $435.5 million in Q2 2022.
  • Average Total Current Liabilities over 5 years is $534.1 million, with a median of $518.8 million recorded in 2021.
  • Peak YoY movement for Total Current Liabilities: skyrocketed 168.45% in 2021, then dropped 28.13% in 2022.
  • A 5-year view of Total Current Liabilities shows it stood at $499.8 million in 2021, then dropped by 8.72% to $456.2 million in 2022, then rose by 17.71% to $537.0 million in 2023, then grew by 5.58% to $567.0 million in 2024, then rose by 25.65% to $712.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $712.4 million in Q4 2025, $670.7 million in Q3 2025, and $622.1 million in Q2 2025.